Blog - April 2018
With the demand in high potency containment systems continuing to rise, it has never been more critical to have adequate containment strategies and appropriate verification in place. Yet, it is also crucial to understand the variations in validation testing available and the potential challenges and differences posed by the interpretation of results.
Our global product manager, Michael Avraam speaks to European Pharmaceutical Manufacturer about the considerations surrounding containment performance testing and data collection methods. Michael also discusses the techniques available to help ensure efficient containment performance testing moving forward. You can read the full article in EPM here.
INTERPHEX 2018 is just around the corner and in the lead up, ChargePoint Inc's president Chris Rombach has gathered with other industry experts in the latest pre-show blog to discuss the challenges and opportunities facing the industry in 2018.
With the rising demand for manufacturing using highly potent active pharmaceutical ingredients (HPAPIs) being a huge trend in the industry, Chris talks about the flourishing biotech and oncology markets as well as the increase in 'virtual' pharmaceutical companies and their impact. He also discusses how the containment sector is expected to grow alongside this demand, as high potency manufacturers search for the best containment strategy. Ultimately, this means that more innovative solutions are coming to the market, particularly that of SMART monitoring technology.